We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.55%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$58.1B
AUM Growth
Cap. Flow
+$54.1B
Cap. Flow %
93.11%
Top 10 Hldgs %
11.25%
Holding
6,476
New
6,347
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$426M
2
USB icon
US Bancorp
USB
+$321M
3
CTRA
Coterra Energy
CTRA
+$307M
4
XEC
CIMAREX ENERGY CO
XEC
+$275M
5
IVZ icon
Invesco
IVZ
+$273M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 11.42%
2 Consumer Discretionary 7.94%
3 Energy 6.81%
4 Technology 6.81%
5 Industrials 5.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATRS
6301
CALL
DELISTED
Antares Pharma, Inc.
ATRS
$2K ﹤0.01%
+400
New +$1.54K
TIVO
6302
DELISTED
Tivo Inc
TIVO
$2K ﹤0.01%
+67
New +$1.57K
ILG
6303
PUT
DELISTED
ILG, Inc Common Stock
ILG
$2K ﹤0.01%
+100
New +$2.06K
RSO
6304
CALL
DELISTED
Resource Capital Corp.
RSO
$2K ﹤0.01%
+75
New +$1.92K
BV
6305
PUT
DELISTED
Bazaarvoice, Inc.
BV
$2K ﹤0.01%
+200
New +$1.56K
RT
6306
DELISTED
Ruby Tuesday Georgia
RT
$2K ﹤0.01%
+249
New +$2.28K
ACUR
6307
PUT
DELISTED
Acura Pharmaceuticals
ACUR
$2K ﹤0.01%
+180
New +$2.03K
ENZN
6308
PUT
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$2K ﹤0.01%
+1,000
New +$2.93K
MSO
6309
PUT
DELISTED
MARTHA STEWART LIVING OMNIMEDIA INC
MSO
$2K ﹤0.01%
+1,000
New +$2.44K
TTTM
6310
DELISTED
T3 MOTION, INC COM STK NEW
TTTM
$2K ﹤0.01%
+59,951
New +$7.94K
XIDE
6311
CALL
DELISTED
EXIDE TECHNOLOGIES NEW COM
XIDE
$2K ﹤0.01%
+17,000
New +$15.2K
AES.PRC.CL
6312
DELISTED
AES Corporation Class C Preferred
AES.PRC.CL
$2K ﹤0.01%
+41
New +$2.06K
WRES
6313
CALL
DELISTED
WARREN RESOURCES INC
WRES
$2K ﹤0.01%
+600
New +$1.68K
CHGS
6314
DELISTED
CHINA GENGSHENG MINERALS, INC. COMMON STOCK (NV)
CHGS
$2K ﹤0.01%
+16,178
New +$3.22K
BCRX icon
6315
PUT
BioCryst Pharmaceuticals
BCRX
$2.64B
$1K ﹤0.01%
+800
New +$1.38K
CVBF icon
6316
CALL
CVB Financial
CVBF
$4.02B
$1K ﹤0.01%
+100
New +$1.11K
DHT icon
6317
CALL
DHT Holdings
DHT
$2.93B
$1K ﹤0.01%
+200
New +$889
EBS icon
6318
CALL
Emergent Biosolutions
EBS
$228M
$1K ﹤0.01%
+100
New +$1.45K
EXTR icon
6319
PUT
Extreme Networks
EXTR
$3.14B
$1K ﹤0.01%
+300
New +$1K
GERN icon
6320
CALL
Geron
GERN
$1.05B
$1K ﹤0.01%
+529
New +$575
KRO icon
6321
KRONOS Worldwide
KRO
$963M
$1K ﹤0.01%
+90
New +$1.45K
LCTX icon
6322
PUT
Lineage Cell Therapeutics
LCTX
$283M
$1K ﹤0.01%
+372
New +$1.19K
PLUG icon
6323
CALL
Plug Power
PLUG
$3.1B
$1K ﹤0.01%
+3,200
New +$890
WWR icon
6324
PUT
Westwater Resources
WWR
$77.2M
$1K ﹤0.01%
+1
New +$1.43K
XYL icon
6325
Xylem
XYL
$28.8B
$1K ﹤0.01%
+47
New +$1.3K

Similar funds

Ken Griffin's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Ken Griffin, which disclosed 6,476 positions worth $58.1B. Its ten largest holdings account for 11% of the portfolio.

Its largest position is Apple: 27,671,756 shares worth $391M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, followed by Consumer Discretionary and Energy.

  • Ken Griffin's largest Q2 2013 buy was Apple: 27,671,756 shares worth $391M.
  • Ken Griffin's ten largest holdings make up 11% of its $58.1B portfolio in Q2 2013.
  • Ken Griffin disclosed 6,476 positions in Q2 2013, its first 13F filing on record.

Based on Citadel Advisors's 13F filing for Q2 2013, filed 14 Aug 2013.